BioSyent (CVE:RX) Stock Crosses Below Fifty Day Moving Average – Here’s Why

BioSyent Inc. (CVE:RX)’s share price crossed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$11.29 and traded as low as C$10.96. BioSyent shares last traded at C$11.00, with a volume of 1,550 shares changing hands.

BioSyent Trading Up 0.4 %

The company has a 50 day moving average of C$11.29 and a 200 day moving average of C$10.93. The firm has a market cap of C$127.49 million, a P/E ratio of 18.33 and a beta of 0.93. The company has a debt-to-equity ratio of 3.19, a quick ratio of 6.91 and a current ratio of 6.13.

Insiders Place Their Bets

In other BioSyent news, insider FAX Capital Corp. sold 112,400 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of C$11.28, for a total transaction of C$1,267,557.28. Also, Senior Officer Robert Joseph March sold 4,775 shares of the stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of C$11.65, for a total value of C$55,628.75. Insiders sold 349,144 shares of company stock valued at $3,903,370 over the last ninety days. Corporate insiders own 33.65% of the company’s stock.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.